FDA Transparency Initiative: Improving Transparency to Regulated Industry
Document ID: FDA-2009-N-0247-0260
Comments
Total: 14
-
AdvaMed - Comment
Posted : 01/31/2011 ID ：FDA-2009-N-0247-0262 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Animal Health Institute (AHI) - Comment
Posted : 03/03/2011 ID ：FDA-2009-N-0247-0263 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Sue Saunders - Comment
Posted : 03/03/2011 ID ：FDA-2009-N-0247-0264 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Lundbeck Inc. - Comment
Posted : 03/03/2011 ID ：FDA-2009-N-0247-0265 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Johnson & Johnson - Comment
Posted : 03/07/2011 ID ：FDA-2009-N-0247-0266 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Pacific Coast Council of Customs Brokers and Freight Forwarders Assns, Inc. - Comment
Posted : 03/07/2011 ID ：FDA-2009-N-0247-0267 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
NCBFAA - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0268 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
RTI Biologics, Inc. - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0269 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Medical Imaging & Technology Alliance (MITA) - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0270 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Plasma Protein Therapeutics Association (PPTA) - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0271 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
AdvaMed - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0272 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
Biotechnology Industry Organization (BIO) - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0273 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
The International Consortium of Innovation and Quality in Pharmaceutical Development - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0274 Agency : FDA -
Mar 08,2011 11:59 PM ET
-
GlaxoSmithKline - Comment
Posted : 03/11/2011 ID ：FDA-2009-N-0247-0275 Agency : FDA -
Mar 08,2011 11:59 PM ET